Aquestive Therapeutics (AQST.US) received its first coverage from Leerink Partners, with outperform rating and a target price of $8.00.
Aquestive Therapeutics(AQST.US)获Leerink Partners首次覆盖，给予优于大市评级, 目标价8.00美元。
Aquestive Therapeutics (AQST.US) was first covered by Leerink Partners, which gave it an superior market rating and a target price of $8.00.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.